Related Experiment Video
Updated: Apr 4, 2026

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
Published on: April 4, 2018
Integrating 730,947 exome sequences with clinical literature improves gene discovery
Jeremy Guez1,2,3, Julia K Goodrich2,3, Mikhail A Moldovan4
1Analytic and Translational Genetics Unit, Massachusetts General Hospital, Boston, MA, USA.
The new Genome Aggregation Database v4 (gnomAD v4) expands exome sequencing data by fivefold, enhancing the power to detect genetic constraint and improve rare disease gene discovery. This resource accelerates genetic discovery and diagnosis for various conditions.
Area of Science:
- Genomics
- Human Genetics
- Bioinformatics
Background:
- Accurate allele frequency estimation is crucial for genetic discovery, rare disease diagnosis, and population genetics.
- Previous releases of the Genome Aggregation Database (gnomAD) have been instrumental in these areas.
Purpose of the Study:
- To present Genome Aggregation Database version 4 (gnomAD v4), featuring a fivefold increase in exome sequences.
- To enhance the detection of selective constraint and improve disease gene prediction.
- To establish a unified framework for accelerating gene discovery and rare disease diagnosis.
Main Methods:
- Incorporated exome sequences from 730,947 individuals into gnomAD v4.
- Developed a novel loss-of-function (LoF) annotation pipeline with 90% precision for variant classification.
- Integrated gene-disease associations, biological features, and refined constraint metrics within a Bayesian framework.
Main Results:
- Demonstrated increased statistical power for detecting strong selective constraint with larger sample sizes.
- The improved LoF pipeline and inclusion of deleterious missense variants enhance disease gene detection, especially for short or gain-of-function genes.
- Achieved state-of-the-art prediction of gene-disease relevance, highlighting under-characterized genes linked to severe phenotypes.
Conclusions:
- gnomAD v4 significantly advances the scale and accuracy of human genetic variation data.
- The developed methods improve the identification and characterization of disease-associated genes.
- This work provides a powerful framework for accelerating genetic discovery and improving the diagnosis of rare genetic disorders.
More Related Videos
05:51A Strategy to Identify de Novo Mutations in Common Disorders such as Autism and Schizophrenia
Published on: June 15, 2011
13:24Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies
Published on: April 11, 2016
Related Concept Videos
Genomics
Next-generation Sequencing
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features....
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Pharmacogenomics: Identification of New Drug Targets
Sanger Sequencing
Exon Recombination
Exon shuffling follows “splice frame rules.” Each exon...